Skip to content
Recall Observatory FDA recall evidence

Drug product

Candesartan Cilexetil and Hydrochlorothiazide Tablets, USP 32 mg/12.5 mg, packaged in a) 90-count bottles (NDC 0378-3002-77) and b) 500-count bottles (NDC 0378-3002-05), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

D-0049-2021

October 02, 2020

Class III

Product summary

Firm
Mylan Pharmaceuticals Inc.
Event
Event 86520
Status
Terminated
Classification
Class III
Quantity
10,695 bottles
Official record key
drug-enforcement:D-0049-2021

Official wording

Reason: Out-of-specification organic impurity results obtained during routine stability testing.

Code information: Lot #: a) 8095666, Exp. Date July 2021 b) 3104664, Exp. Date July 2021

Distribution pattern: Nationwide within the United States

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Out-of-specification